Clinical Trials on MYH9 Trombocitopenia relacionada

Total 954 results

IRCCS Policlinico S. Matteo
GlaxoSmithKline; University of Pavia; Azienda Ospedaliera di Padova; Azienda Ospedaliera... and other collaborators

Completed

Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease

Blood Platelet Disorders

Italy
Assistance Publique - Hôpitaux de Paris

Completed

Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia (MAGIC-MYH9)

May-Hemalin | Fechtner Syndrome (Disorder) | Epstein Syndrome (Disorder) | MYH9 Related Disorders

France
Huazhong University of Science and Technology

Recruiting

Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy (hetrombopag)

Malignant Tumors of the Digestive System | Trombocitopenia

China
Weill Medical College of Cornell University
Columbia University; New York Presbyterian Hospital

Completed

A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia

Alloimmune Thrombocytopenia | Fetal Alloimmune Thrombocytopenia

United States
Sylvia Elzek

Unknown

Neonatal Thrombocytopenia Among Newborns Admitted to Neonatal Intensive Care Unit

Thrombocytopenia Neonatal
Central Hospital, Nancy, France

Recruiting

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery (TicTac)

Heparin-induced Thrombocytopenia

France
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care. (REPROHEP)

Heparin-induced Thrombocytopenia
University of Arizona
American College of Clinical Pharmacy

Recruiting

Pharmacogenomics of Heparin-Induced Thrombocytopenia (PHIT)

Heparin-induced Thrombocytopenia

United States
Veralox Therapeutics
Celerion

Completed

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Heparin-induced Thrombocytopenia

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Marshall University

Unknown

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) (HIT)

Heparin-induced Thrombocytopenia

United States
Ottawa Hospital Research Institute

Unknown

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia (HIT)

Heparin-induced Thrombocytopenia (HIT)

Canada
Assistance Publique Hopitaux De Marseille

Withdrawn

Genotyping of Human Platelet Alloantigens : Non-invasive Prenatal Diagnosis

Neonatal Thrombocytopenia Isoimmunization Maternal-fetal

France
Napolitano Mariasanta
Regione Sicilia

Terminated

Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia (MICE)

Thrombocytopenia | Primary Thrombocytopenia,Unspecified | Thrombocytopenia Chemotherapy Induced

Italy
CHIR-Net
University Medicine Greifswald

Completed

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients (HITOLT)

Liver Transplantation | Heparin-induced Thrombocytopenia

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Heparin-induced Thrombocytopenia Type II

France
Vanderbilt University Medical Center
American Heart Association

Completed

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Heparin-induced Thrombocytopenia

United States
Central Hospital, Nancy, France

Completed

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation (TIH ECMO)

Heparin-induced Thrombocytopenia
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO)

Heparin Induced Thrombocytopenia

United States
Rallybio IPA, LLC

Not yet recruiting

Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization

Fetal and Neonatal Alloimmune Thrombocytopenia
GlaxoSmithKline

Completed

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Acute HIT II (Heparin-induced Thrombocytopenia Type II)
Medical University of Vienna

Recruiting

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Heparin-induced Thrombocytopenia

Austria
Methodist Health System

Recruiting

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

Baseline Thrombocytopenia

United States
Rallybio IPA, LLC

Recruiting

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Fetal and Neonatal Alloimmune Thrombocytopenia

United States, Canada, Netherlands, Norway, United Kingdom, Sweden, Germany
University Hospital, Strasbourg, France

Recruiting

Performance Evaluation of the Biological Diagnosis of HIT (HIT)

Heparin-induced Thrombocytopenia (HIT)

France
Centre Hospitalier Universitaire de Besancon

Completed

Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients (TIH)

Heparin-induced Thrombocytopenia (HIT)

France
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Chemotherapy-Induced Thrombocytopenia
Sobi, Inc.

Completed

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Chemotherapy-induced Thrombocytopenia

United States, China, Hungary, Poland, Russian Federation, Serbia, Ukraine
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Chemotherapy-induced Thrombocytopenia

China
BioMAS Ltd

Terminated

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Chemotherapy Induced Thrombocytopenia

Israel
Pfizer

Terminated

Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia

Severe Thrombocytopenia

United States
Leiden University Medical Center
Sanquin Research & Blood Bank Divisions; Landsteiner Foundation for Blood Transfusion

Completed

Towards Routine HPA-screening In Pregnancy to Prevent FNAIT (HIP)

Fetal and Neonatal Alloimmune Thrombocytopenia

Netherlands
Prophylix Pharma AS
Larix A/S; Fraunhofer Institute for Molecular Biology and Applied Ecology; Deutsches... and other collaborators

Completed

Kinetics of Blood Platelets Transfused to Healthy Subjects

Fetal and Neonatal Alloimmune Thrombocytopenia

Germany
McMaster University

Terminated

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Heparin-induced Thrombocytopenia

Canada
Qilu Pharmaceutical Co., Ltd.

Recruiting

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Massachusetts General Hospital
Bristol-Myers Squibb

Terminated

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Heparin-induced Thrombocytopenia | Heparin-induced Thrombocytopenia and Thrombosis

United States
Centre Hospitalier Universitaire, Amiens

Recruiting

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer (PLATELETSTREAM)

Platelet Aggregation | Heparin-induced Thrombocytopenia | Platelet Activation | Platelet Disorder

France
Boston Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI); Beth Israel Deaconess Medical... and other collaborators

Active, not recruiting

Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates

Neonatal Thrombocytopenia

United States
Singapore General Hospital
DSO National Laboratories; Health Sciences Authority, Singapore

Completed

Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients

Hypoproliferative Thrombocytopenia

Singapore
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia. (TIH-FM)

Heparin-induced Thrombocytopenia

France
Damian Ratano
The PSI Foundation, Ontario

Active, not recruiting

Thrombo-Elastography Guided Management of ECMO (TEGMO)

Extracorporeal Circulation of Blood; Thrombocytopenia

Canada
Medstar Health Research Institute
GlaxoSmithKline

Unknown

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Heparin-Induced Thrombocytopenia

United States
The First Affiliated Hospital of Dalian Medical...
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaborators

Recruiting

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury (Circular)

Cancer Treatment Induced Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Herombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Herombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Avatrombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Eltrombopag | Chemotherapy-induced Thrombocytopenia

China
Etablissement Français du Sang
University Hospital, Grenoble

Completed

Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP)

Aplasia With Expected Thrombocytopenia

France
Angde Biotech Pharmaceutical Co., Ltd.

Unknown

A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Chemotherapy-induced Thrombocytopenia

China
Jiangsu HengRui Medicine Co., Ltd.

Withdrawn

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Chemotherapy-Induced Thrombocytopenia

Clinical Trials on MYH9 Trombocitopenia relacionada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations